Myelin-associated glycoprotein (MAG) is a sialic acid-binding Ig-family lectin that functions in neuronal growth
Introduction
Adult mammalian CNS myelin contains growth inhibitory factors that contribute to the regenerative failure of severed axons following injury (Schwab, 1993) . Several myelin inhibitors have been identified and most of the attention has focused on MAG, Nogo-A, and OMgp (Filbin, 2003; Xie and Zheng, 2008) .
The Nogo receptors NgR1 and NgR2 show overlapping, yet distinct, binding preferences for myelin inhibitors. Nogo-A and OMgp bind selectively and with high affinity to NgR1 (Liu et al., 2006) , while MAG binds preferentially to NgR2 but also interacts with NgR1 . In vitro, NgR1 is necessary for growth cone collapse in response to acutely presented myelin inhibitors (Kim et al., 2004; Chivatakarn et al., 2007) , but is dispensable for neurite outgrowth inhibition on substrate-bound Nogo-66 (Zheng et al., 2005) or MAG or OMgp Venkatesh et al., 2007; Williams et al., 2008) . Mechanistically, this apparent dichotomy of the role of NgR1 in neuronal growth inhibitory responses is poorly understood. Physiological NgR1 signaling limits experience-dependent plasticity in the visual cortex (McGee et al., 2005) , and in the adult hippocampus, NgR1 regulates activity-dependent synaptic strength and dendritic spine morphology . Following CNS injury, NgR1 limits axon collateral sprouting but not long-distance regenerative growth of severed corticospinal tract fibers (Kim et al., 2004; Zheng et al., 2005; Cafferty and Strittmatter, 2006) .
MAG is a member of the siglec family of sialic acid-binding Ig lectins and uses neuronal cell-type-specific mechanisms to mediate growth inhibition. Cerebellar granule neurons (CGNs) but not dorsal root ganglion (DRG) neurons deficient for complex gangliosides are more resistant to MAG inhibition. In retinal ganglion cells (RGCs), hippocampal and DRG neurons, functional depletion of gangliosides or NgR1 alone is not sufficient to attenuate MAG inhibition. Simultaneous loss of terminal sialic acids and NgR1, however, significantly attenuates MAG inhibition (Mehta et al., 2007; Venkatesh et al., 2007) . A receptor complex comprised of NgR1, Lingo-1, and p75 or TROY has been implicated in signaling Nogo-66, OMgp, and MAG inhibition of neurite outgrowth (Yiu and He, 2006) . In vitro, p75 is important for growth inhibition of DRG neurons, but neither p75 nor TROY is necessary for MAG inhibition of CGNs or RGCs (Zheng et al., 2005; Venkatesh et al., 2007) . MAG-induced repulsive growth cone steering requires the presence of an arginine-glycineaspartate (RGD)-dependent interaction with neuronal ␤1-integrin (Goh et al., 2008) . The ligand-binding domain (LBD) of NgR1 is composed of 8.5 canonical LRRs flanked by cysteine-rich LRR-NT and LRR-CT cap domains. The LBD harbors overlapping, yet distinct, binding pockets for Nogo, OMgp, and MAG (Schimmele and Plückthun, 2005; Laurén et al., 2007) . In soluble form, the NgR1 LBD [NgR1(310)] has CNS myelin inhibitor antagonistic properties in vitro Liu et al., 2002; He et al., 2003; Zheng et al., 2005) . Following spinal cord injury, NgR1(310)-Fc promotes sprouting and regenerative growth of severed corticospinal and raphespinal fibers (Li et al., 2004; Wang et al., 2006) .
Here, we define the structural basis of the MAG association with NgR1 and NgR2 and develop a soluble chimeric Nogo receptor variant with potent CNS myelin antagonistic properties.
Materials and Methods
Recombinant DNA constructs. Chimeric receptors were generated by PCR using rat NgR1, NgR2, or NgR3 cDNA templates and assembled in the expression vector pMT21 (Venkatesh et al., 2005) . To fuse PCRamplified receptor fragments, either endogenous restriction enzyme sites or newly introduced restriction sites were used that resulted in either no amino acid substitution or conservative substitutions. None of the conserved leucine or phenylalanine residues critical for the tertiary structure of the LRR cluster or cysteine residues in the LRRNT-and LRRCT-cap domains implicated in disulfide bonds were altered. N-terminal NgR1 and NgR2 deletion mutants were fused to the signal sequence of peptidylglycine ␣-amidating monooxygenase (PAM) followed by a myc epitope and a five residue glycine (Gly 5 )-spacer. Soluble receptor constructs were fused C-terminally to the Fc portion of human IgG1 and assembled in the expression vectors pcDNA1 or pcDNA3 (Invitrogen). Membrane-bound myc-tagged Nogo-66 (myc-Nogo-66-Npn1) was constructed by fusing human Nogo-66 to the transmembrane and cytoplasmic portion of rat neuropilin-1 in the pSecTag expression vector. Soluble full-length MAG ectodomain and deletion mutants were N-terminally fused to the PAM signal sequence, followed by a myc epitope and a Gly 5 -spacer and C-terminally fused to Fc. MAG constructs were assembled in pcDNA3.0 (Invitrogen), sequenced, and analyzed by ELISA and Western blotting. Constructs included MAG(1-5)-Fc (residues S17-A506), MAG(3-5)-Fc (residues L234 -A506), MAG(1-3)-Fc (residues S17-A325), and MAG(1-3) R118A -Fc, harboring an arginineto-alanine point mutation at residue 118. For a complete list of all NgR1 and NgR2 expression constructs generated, see supplemental Table 1 (available at www.jneurosci.org as supplemental material).
Fusion protein production and purification. Soluble fusion proteins were produced in transiently transfected HEK293T cells using Lipofectamine 2000. Conditioned cell culture supernatant (OptiMEM, Invitrogen) was collected and tumbled overnight with protein A/G beads (Merck Biosciences). After rinsing with PBS, proteins were eluted with 0.1 M glycine, pH 2.5, and dialyzed (10 kDa cutoff; Thermo Fisher Scientific) against PBS. The purity of fusion proteins was verified by SDS-PAGE followed by Coomassie staining. Before protein A/G purification, some batches of soluble receptor were preincubated with Vibrio cholerae neuraminidase (Sigma) (1 mU/ml) in 1 mM CaCl 2 . Siglec3-Fc was obtained from R&D Systems. MAG(1-5)-Fc was either purchased from R&D Systems or purified from conditioned media of transiently transfected HEK293T cells.
Receptor binding studies. For ligand-receptor binding studies, COS-7 cells were plated at ϳ80% confluency onto poly-D-lysine (50 g/ml, Sigma)-coated 24-well plates (Costar, 3525) and cultured overnight before transfection with NgR1 or NgR2 receptor variants, L-MAG, OMgp, or Nogo-66-Npn1 plasmid DNA using Lipofectamine 2000 (Invitrogen). The next day, COS-7 cells were rinsed with OptiMEM and incubated for 75 min with Fc-tagged fusion proteins preclustered with anti-human IgG conjugated to human placental alkaline phosphatase (AP) (Promega). Unbound fusion protein was removed by extensive rinsing with Opti-MEM. Cells were then fixed with 1% formaldehyde in 60% acetone, rinsed twice in HBHA (HBS supplemented with 0.05% horse serum, 0.5% NaN 3 ), and rinsed once in HBS (Cellgro). Endogenous phosphatases were heat-inactivated by incubation at 65°C for 90 min. Binding of fusion proteins was visualized by developing the AP reaction with NBT/ BCIP substrate (Sigma). The color reaction was stopped by rinsing wells with PBS. For some binding experiments, COS-7 cells were pretreated with VCN (10 mU/ml; Sigma) or ␣-2,3 neuraminidase (500 mU/ml,New England Biolabs). To confirm that COS-7 cells do not express Fc receptors endogenously, AP-Fc was used as a negative control for binding studies to untransfected cells. No binding was detected with AP-Fc at concentrations up to 50 nM.
Normalization of receptor cell surface expression. To assess cell surface expression of Nogo receptor constructs, transiently transfected COS-7 cells were immunolabeled with anti-NgR1, -NgR2, or -NgR3 polyclonal immune sera under nonpermeabilizing conditions (Venkatesh et al., 2005) . Because different constructs contain different receptor fragments of variable length, cell surface receptor expression was normalized with chimeric rabbit/human monoclonal antibodies M5 (1 g/ml), P14 (1 g/ml), or mouse monoclonal IgG 9B11 (1 g/ml, anti-myc, Cell Signaling Technology). M5 and P14 recognize epitopes located in the distal stalk region adjacent to the GPI anchor (Hofer et al., 2007) . Antibodies were diluted in PBS in 1% horse serum as described previously (Hofer et al., 2007) . Bound antibody was detected with anti-human IgG (Promega, 1 g/ml) for M5 and P14 or anti-mouse IgG (0.75 g/ml) for 9B11. For quantification of relative receptor cell surface expression levels, bound M5, P14, or anti-myc were detected with an anti-human or anti-mouse IgG conjugated to AP (Promega). Several receptor deletion constructs, including NgR1
LRRCTϩstalk and NgR2 LRRCTϩstalk constructs, were N-terminally myc-tagged (supplemental Table 1 , available at www. jneurosci.org as supplemental material). Anti-myc staining was used to calibrate the relative binding strength of the NgR1-and NgR2-specific monoclonal IgGs M5 and P14. Cell surface expression levels of all receptor mutants was assessed with M5 or P14 under nonpermeabilizing conditions and allowed for comparison of their relative cell surface expression levels. Briefly, following incubation with M5 or P14 IgG in PBS and 1% horse serum, cells were rinsed three times with PBS. For quantification of bound antibody, cells were lysed in 10 mM HEPES, pH 7.0, and 0.1% Triton X-100 at 65°C for 2 h. The AP activity in lysates was quantified with a Microplate Reader (Bio Tek Instruments) by measuring the absorption at 415 nm. For each receptor construct, ligand binding was normalized to cell surface receptor expression levels.
Quantification of binding. The relative strength of protein-protein interactions was measured as described previously (Venkatesh et al., 2005) . Relative binding affinities to receptor variants were normalized to receptor surface expression and plotted against AP-Nogo-66 binding to wildtype NgR1 (100%), OMgp-AP binding to wild-type NgR1 (100%), or binding of oligomerized MAG-Fc to NgR1 (100%). Binding of soluble NgR1-Fc to membrane-bound L-MAG, OMgp, and Nogo-66-Npn1 was each set to 100% and used for normalization of relative binding strength and comparison to the fusion proteins NgR1(310)-Fc, NgR2-Fc, Fc, -Fc binding to NgR1, NgR2, and MAG was quantified using Microsuite Five (Olympus) quantification software. For this method, COS-7 cells were not lysed, but were fixed onto the plate, heat inactivated at 65°C, and developed in NBT/BCIP substrate. Black and white images were taken with a CC-12 CCD camera attached to an IX71 Olympus microscope. Pixel intensity of 30 -50 cells with positive binding was compared with pixel intensity of adjacent cells with no binding. Comparison of the digital imaging method (Microsuite Five software) and the cell lysis method (Venkatesh et al., 2005) to quantify ligand binding yielded similar results.
Analysis of NgR1 and NgR2 glycosylation in neural tissue. Rat P7 forebrain homogenate (50 g) was treated with VCN (10 mU/mg) for 1 h at 37°C in a reaction buffer containing 5 mM sodium acetate and 1 mM CaCl 2 , pH 5.5. For double digestion with PNGase F, VCN-treated samples were denatured by boiling for 10 min in 0.5% SDS and 40 mM DTT. Samples were then digested with 3 l of PNGaseF (500 U/ml; New England Biolabs) in 1% NP-40, 50 mM sodium phosphate, pH 7.5, for 1 h at 37°C. Adult brains of Galgt1 heterozygous (ϩ/Ϫ) and mutant (Ϫ/Ϫ) mice were kindly provided by R. Schnaar (Johns Hopkins University, Baltimore, MD). The neocortices from Galgt1 (ϩ/Ϫ) and (Ϫ/Ϫ) brains were dissected and lysed in modified RIPA buffer (50 mM Tris HCl, 150 mM NaCl, 1% NP-40, 1 mM MgCl 2 , and 0.25% sodium deoxycholate) and incubated with or without VCN (10 mU/mg) and protease inhibitor mix (Sigma) for 1 h at 37°C. The reaction was stopped by incubation in Laemmli buffer/␤-mercaptoethanol. Following boiling, protein samples were separated by SDS-PAGE and blotted on polyvinyl membranes. Mouse NgR1 and NgR2 were detected with a goat anti-NgR1 or antiNgR2 immune serum.
For two-dimensional (2-D) gel electrophoresis, we used Triton X-100-insoluble lipid raft fractions isolated from P14 rat brain extracts by flotation in a sucrose gradient as described previously (Venkatesh et al., 2005) . A total of 50 g of lipid raft protein was subjected to 2-D gel electrophoresis in a pH gradient of 4 -9.5 (Kendrick Labs). For Western blotting, the membrane was probed with a polyclonal rabbit anti-NgR1 immune serum (Venkatesh et al., 2005) followed by anti-caveolin (22 kDa) as a marker for lipid rafts.
ELISA of soluble MAG fusion proteins. Goat anti-human IgG (10 g/ ml; Millipore Bioscience Research Reagents) was used to coat 96-well ELISA plates (BD Biosciences) overnight at 4°C. After rinsing with PBS, Fc-tagged MAG deletion constructs were applied, incubated for 2 h at 37°C, rinsed in PBS, and blocked in 1% BSA in PBS for 1 h at room temperature. Anti-MAG 513 antibody (Millipore Bioscience Research Reagents) was applied overnight at 4°C, wells were rinsed and then incubated with AP-conjugated anti-mouse Fc (Promega) for 1 h at room temperature. Bound AP activity was quantified using a Microplate Reader (Bio Tek Instruments) to measure absorption at 415 nm.
Myelin preparation. Spinal cord myelin was isolated from 2 to 3 months old female Sprague Dawley rats using a modified version of the method described by Colman et al. (1982) . Briefly, spinal cords from 5 rats were dissected (2.1 g) and homogenized in 21 ml of ice-cold lowsucrose buffer [0.25 M sucrose, 10 mM HEPES pH 7.4, 3 mM DTT, 5 mM EDTA, and 210 l of tissue protease inhibitor mix (Sigma)]. The tissue homogenate was centrifuged at 4°C for 2 min at 1000 rpm (Beckman, Allegra 6R) and the supernatant was stored on ice. The pellet was homogenized in 10 ml of low-sucrose buffer and centrifuged as described. The resulting pellet (P1) was frozen and the combined supernatants (25 ml, SN1) were adjusted to 1.4 M sucrose by adding 55 ml of ice-cold high sucrose buffer (1.9 M sucrose, 10 mM HEPES pH 7.4, 3 mM DTT, 5 mM EDTA, and 1:200 protease inhibitor mix). In a 36 ml centrifuge tube (Sorvall 630/36 rotor tubes), 28 ml of spinal cord extract were overlaid with 5 ml of ice-cold 0.85 M sucrose buffer (0.85 M sucrose, 10 mM HEPES pH 7.4, 3 mM DTT, 5 mM EDTA, and 1:200 protease inhibitor) and 3 ml of 0.25 M low-sucrose buffer and then spun for 1 h at 75,000 ϫ g (Sorval swing-out rotor 630; 20,000 rpm). Myelin was enriched and collected from the 0.25/0.85 sucrose interphase (M1). Microsomes and polysomes were collected at the 0.85/1.4 M sucrose interphase (M2). M1 and M2 were each diluted 1:10 in ice-cold 10 mM HEPES, pH 7.4, homogenized on ice, and spun for 20 min at 75,000 ϫ g (first osmotic shock). The pellets were resuspended in 10 mM HEPES, homogenized, and centrifuged as described. The osmotic step was repeated once. The pellets were resuspended in 10 mM HEPES and the protein concentration (pellet P3 ϭ microsomes/polysomes and pellet P4 ϭ myelin membranes) was determined using the Pierce protein concentration method. Western blot analysis with anti-MAG (B11F7, 1:1000 mouse monoclonal Ab, kindly provided by R. Quarles, National Institutes of Health/National Institute of Neurological Disorders and Stroke, Bethesda, MD), anti-NogoA/B and anti-OMgp (1:1000 goat polyclonal Abs, R&D Systems), anti-MBP (1:1000 mouse monoclonal Ab, Covance), and anti-tubulin (Sigma, 1:2000 mouse) were done on microsome/polysome and myelin fractions to assess the quality of the prepared myelin and the relative distribution of inhibitors among the two fractions (supplemental Fig. S8 , available at www.jneurosci.org as supplemental material). The myelin fractions were aliquoted and stored at Ϫ80°C. For functional assays, membrane proteins of fraction P4 were extracted with 1% CHAPS buffer for 4 h at 4°C before centrifugation to remove nonsoluble proteins.
Affinity precipitation. Myelin membranes (1 mg) were lysed in buffer containing 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, and 1% CHAPS overnight at 4°C with tumbling. Following centrifugation at 14,000 rpm for 10 min to remove insoluble material, lysates were tumbled for 4 h at 4°C in the presence of 0.5% BSA and protease inhibitor in the presence of 5 g of NgR OMNI -Fc, NgR1(310)-Fc, NgR2 LRRCTϩstalk -Fc, or anti-MAG 513 antibody or control IgG. Protein G Plus/protein A-agarose beads (Merck Biosciences) were added and tumbled at 4°C for 2 h. Affinity precipitation was performed as described previously , and precipitates were analyzed by SDS-PAGE and immunoblotting with anti-MAG B11F7 (generous gift from R. Quarles). Recombinant OMgp (R&D Systems) was used for affinity precipitation experiments with soluble Nogo receptor fusion proteins Neurite outgrowth assay. Glass coverslips (Propper) were acid etched, rinsed in 100% ethanol, and dried thoroughly before being placed in 24-well plates. Nitrocellulose (1 cm 2 ) was dissolved in methanol (1 ml), coated onto acid-etched glass coverslips, and dried completely. MAG(1-5)-Fc (R&D Systems), Siglec3-Fc (R&D Systems), bovine serum albumin (BSA), or rat spinal cord myelin membranes dissolved in 1% CHAPS was adsorbed onto the nitrocellulose-coated glass coverslips at ambient temperature for 1 h. Protein was coated at specified concentrations (see Results for details) and wells never dried. Unbound soluble protein was rinsed off with PBS before addition of poly-D-lysine (Sigma) at 100 g/ml for 1 h. After rinsing, the wells were coated with laminin (1.5 g/ml; Invitrogen) for 1 h for postnatal rat CGN cultures. Percoll-purified P7-P8 rat CGNs were prepared concurrently (Venkatesh et al., 2005) , plated at a concentration of 65,000 per well, and cultured for 16 h before fixation in 4% paraformaldehyde. For E18 rat cortical neurons, fibronectin (5 g/ml; EMD Biosciences) was used in place of laminin. E18 rat cortical neurons were prepared as described previously , plated at a concentration of 50,000 neurons per well, and fixed after incubating for 21 h. For experiments with soluble receptor fusion proteins, equal volumes of Ig-purified soluble proteins were added to wells immediately following plating of neurons for a final concentration of 10 g/ml. For dose-response experiments, neurons were plated on a constant amount of substrate-adsorbed MAG(1-5)-Fc (2 g/well), and increasing concentrations of NgR OMNI -Fc, NgR2 LRRCTϩstalk -Fc, or NgR1(310)-Fc (0 -20 g/ml) were added to the culture medium.
For transfection of P7-P8 CGNs the Amaxa nucleofection method was used as described previously (Venkatesh et al., 2005) . Briefly, CGNs were purified in a discontinuous Percoll gradient and cultured in Neurobasal medium with 1ϫ B27 supplement, 25 mM glucose, 1 mM glutamine, and Pen/Strep. For transfection, 5-7 ϫ 10 6 CGNs in 100 l of Nucleofector kit V solution were mixed with 4 g of pEGFP plasmid DNA or a mixture of 3 g of NgR1(LRRCTϩstalk) and 1 g of pEGFP or 3 g of NgR2(LRRCTϩstalk) and 1 g of pEGFP using the O-03 pulsing parameter. Following transfection, CGNs were plated onto confluent monolayers of CHO or CHO-MAG feeder cells and cultured for 20 h. Cells were then fixed and stained by anti-GFP and anti-␤⌱⌱⌱-tubulin (TuJ1, Promega) double immunofluorescence, and neurite length was quantified as described previously (Venkatesh et al., 2005) .
Quantification of neurite length and statistical analysis. Following fixation, neuronal cultures were immunostained with TuJ1. Nine images in the center of each well were acquired at a magnification of 10ϫ using an Olympus IX71 inverted microscope (Olympus) equipped with a DP70 digital camera. Length of neurites approximately equal to or greater than one cell body in diameter was assessed using the UTHSCSA ImageTool for Windows (Venkatesh et al., 2005) . For each condition, between 15 and 350 neurites were counted per assay. All experiments were repeated independently three to five times. For statistical analysis, GraphPad Prism IV was used (unpaired t test). All error bars shown indicate SEM.
Results
The first three Ig-like domains of MAG are sufficient for highaffinity NgR1 and NgR2 binding The MAG ectodomain is composed of five Ig-like domains (Ig1-5), with the lectin activity located toward the N-terminal Ig-like domains (Fig. 1) . Previous studies revealed that a deletion mutant composed of the first three Ig-like domains, MAG(1-3)-Fc, binds strongly and in a sialic acid-dependent manner to the surface of neurons and neuron-like cells (Strenge et al., 1999) . The MAG inhibition site can be dissociated from the sialic acid binding site (Tang et al., 1997) and has recently been mapped to Ig5 (Cao et al., 2007) . To examine the structural basis of MAG binding to NgR1 and NgR2, we generated the soluble MAG ectodomain deletion mutants MAG ( The MAG lectin activity is located within domains Ig1-3 (Kelm et al., 1994) . To assess the contribution of sialic acids for MAG binding to NgR1 and NgR2, we generated MAG (1-3) R118A -Fc, a point mutant with greatly decreased lectin activity (Tang et al., 1997; Vinson et al., 2001) . As shown in Figure 1 , MAG(1-3) R118A -Fc binding to NgR1 and NgR2 is greatly reduced compared with MAG(1-3)-Fc. Proper folding of MAG(1-3)
R118A -Fc was confirmed by ELISA with the conformationspecific anti-MAG antibody 513 (Meyer-Franke et al., 1995) (supplemental Fig. S1 , available at www.jneurosci.org as supplemental material). As an independent control for the integrity of the MAG(1-3) R118A -Fc and MAG(3-5)-Fc fusion proteins, we show that they both participate in MAG homophilic binding (supplemental Fig. S2 , available at www.jneurosci.org as supplemental material).
The MAG lectin activity preferentially binds to ␣2,3-linked terminal sialic acids fused to galactose (NeuAc␣2-3Gal␤1-3Gal-NAc) (Yang et al., 1996; Collins et al., 1997; Schnaar et al., 1998) . To assess whether ␣2,3-linked terminal sialic acids on Nogo receptors contribute to MAG binding, NgR1-and NgR2-expressing COS cells were preincubated with ␣2,3-specific neuraminidase. Following enzyme treatment, MAG(1-3)-Fc binding to NgR1 is reduced by 52 Ϯ 4% and binding to NgR2 is reduced by 61 Ϯ 2% (Fig. 1C,D) . Importantly, Nogo-66 binding to NgR1 is not sialic acid dependent (supplemental Fig. S3 , available at www.jneurosci.org as supplemental material). In summary, our results reveal that the first three Ig-like domains of MAG are sufficient to confer sialic acid-dependent binding of NgR1 and NgR2. When coupled with the observation that MAG(3-5)-Fc fails to complex with NgR1 and NgR2, this suggests that Ig3 is not sufficient and that Ig1 and Ig2 are necessary for NgR1 and NgR2 binding. Consistent with the idea that the Nogo receptor binding site is located in the first two Ig-like domains of MAG, arginine 118 (R118), located in Ig1 of MAG, is important for NgR1 and NgR2 binding. Of interest, R118 is also part of the arginineglycine-aspartate (RGD) motif of MAG, previously shown to be essential for ␤1-integrin binding and growth cone steering (Goh et al., 2008) . In addition, MAG binds in a sialic acid-dependent manner to several gangliosides, including GT1b and GD1a (Collins et al., 1997) . The association of MAG with gangliosides is greatly reduced following mutation of R118 (Vinson et al., 2001 ). Thus, we conclude that residue R118 of MAG is critical for the interaction with gangliosides, ␤1-integrin(s), NgR1 and NgR2.
The bulk of MAG inhibitory activity is associated with MAG(3-5)-Fc
Because construct MAG(3-5)-Fc fails to bind to NgR1 and NgR2, we assessed its ability to inhibit neurite outgrowth of P7-P8 cerebellar granule neurons (CGNs). Similar to substrate-adsorbed MAG(1-5)-Fc, MAG(3-5)-Fc is sufficient to inhibit neurite outgrowth (Fig. 1) . Compared with neurite length of control CGN cultures, substrate adsorbed MAG(1-5)-Fc and MAG(3-5)-Fc lead to a significant inhibition of neurite length ( p Ͻ 0.001). When cultured on MAG(1-3)-Fc substrate, a trend toward decreased neurite length was observed (89.5% of control), however outgrowth was not significantly decreased ( p ϭ 0.24) compared with control CGN cultures (Fig. 1 E) . Thus, our results with purified MAG ectodomain deletion constructs are in agreement with a previous study using MAG mutants stably expressed on the surface of CHO feeder cells (Cao et al., 2007) . Because MAG(3-5)-Fc is sufficient to inhibit neurite outgrowth but does not directly bind to NgR1 or NgR2, we examined whether it binds to any of the previously identified components of the neuronal MAG receptor complex. However when ectopically expressed in COS-7 cells, neither p75 nor Troy, nor Lingo-1, supports binding of MAG(3-5)-Fc (data not shown). Because MAG binding to ␤1-integrin and gangliosides depends on its lectin activity (Vinson et al., 2001; Goh et al., 2008) , MAG(3-5)-Fc is not expected to bind to ␤1-integrins or GT1b. Together, these results imply the existence of a novel, as yet unidentified neuronal binding partner for the MAG inhibitory site located in domains Ig3-5.
Nogo receptors are N-and O-linked sialoglycoproteins
The molecular basis of sialic acid-dependent binding of MAG to NgR1 and NgR2 is not well understood. NgR1 and NgR2 from rat brain lysates undergo a V. cholerae neuraminidase (VCN)-dependent molecular weight drop of 2-3 kDa (Venkatesh et al., 2005) . This may either be due to loss of several terminal sialic acid moieties (each ϳ0.3 kDa) covalently linked to NgRs, or loss of an association with a MAG-binding ganglioside (ϳ2 kDa). A recent study using analytical ultracentrifugation found that NgR1 forms a complex with GT1b (Williams et al., 2008) . To more directly address whether the observed VCN-dependent drop in molecular weight of NgR1 or NgR2 is due to loss of an interaction with complex gangliosides, we analyzed the size of NgR1 and NgR2 from brain lysates of ␤-1,4-N-acetylgalactosaminyltransferase (Galgt1) mutant mice which lack complex gangliosides including the MAG ligands GD1a and GT1b (Kawai et al., 2001) . In wildtype brain lysates, NgR1 and NgR2 migrate at an apparent molecular weight of 65 kDa . Western blotting revealed no difference in the molecular weight of NgR1 and NgR2 from Galgt1 heterozygous and mutant mice. Importantly, following VCN treatment, a ϳ3 kDa drop in molecular weight for NgR1 and NgR2 was observed in neocortical extracts of Galgt1 heterozygous and mutant mice (Fig. 2 A) . This demonstrates that the drop in molecular weight is not due to loss of an association with complex brain gangliosides.
Similar to experiments with recombinant NgR1 expressed in SH-SY5Y cells (Walmsley et al., 2004) , treatment of brain lysates with PNGaseF results in a molecular weight drop and appearance of two discrete NgR1 immunoreactive bands migrating at ϳ58 and 52 kDa. For NgR2, two discrete species of immunoreactive bands are detected, running at ϳ51 and 48 kDa. The combined treatment with PNGaseF and VCN results in an additional decrease in molecular weight. A single band with an apparent molecular weight of 50 kDa for NgR1 and 48 kDa for NgR2 is observed (Fig. 2 B) . This suggests that in mouse brain tissue, the sialylation patterns for NgR1 and NgR2 are not uniform and at least two discrete sialylation patterns can be detected for each receptor. Following PNGaseF treatment, a VCN-dependent shift in molecular weight is still observed, suggesting that NgR1 and NgR2 carry sialic acid moieties on O-linked glycostructures. Because the VCN-dependent molecular weight shift for PNGaseF digested NgR1 and NgR2 is less robust, this also suggests that at least some terminal sialic acid moieties reside on N-glycans. Characteristic for many glycoproteins, 2-D gel electrophoresis of rat brain extracts revealed 15 different isoelectric variants for NgR1 within a pI range of 6 -8.5 (supplemental Fig. S4 , available at www. jneurosci.org as supplemental material).
Incubation of brain lysates with an ␣2,3-neuraminidase revealed a 1-2 kDa drop in the molecular weight for NgR1. No obvious drop in the molecular weight for NgR2 was observed; however, some of the higher molecular weight species of NgR2 are less abundant following ␣2,3-neuraminidase treatment (Fig. 2C ). When coupled with the finding that MAG(1-3)-Fc binding to NgR1 and NgR2 is ␣2,3-neuraminidase sensitive (Fig. 1) , this suggests that NgR1 and NgR2 carry a small number of MAG-binding ␣2,3-linked terminal sialic acid residues. In summary, NgR1 and NgR2 show complex and heterogeneous sialylation patterns. Both receptors carry terminal sialic acid moieties on N-linked and O-linked glycoconjugates, at least some of which participate in MAG binding.
The LRRs of NgR2 are dispensable for MAG binding
The three Nogo receptor family members have an identical overall domain organization and show a high degree of sequence conservation throughout the LRR cluster (composed of the LRRNT-LRR-LRRCT domains). A proline-and serine/ threonine-rich stalk domain connects the LRR cluster to a glycosylphosphatidylinositol (GPI) anchor. The stalk domain of the three receptors is more variable and shows little sequence conservation (Barton et al., 2003 Immunoblotting with anti-NgR1 or anti-NgR2 revealed a decrease of 2-3 kDa in the presence of VCN. Following PNGaseF treatment alone, two distinct immunoreactive bands were observed for both NgR1 (ϳ58 and 52 kDa) and NgR2 (ϳ51 and 48 kDa). A single band with an apparent molecular weight of 50 kDa for NgR1 and 48 kDa for NgR2 is observed following digestion with both enzymes. C, NgR1 in rat cortical lysates treated with ␣2,3-neuraminidase (␣2,3Neu) shows a 1-2 kDa drop in molecular weight. The drop in molecular weight for NgR2 is more subtle, but there is a decrease in the amount of higher molecular weight bands in the NgR2 lane, indicating that some sialic acids moieties on NgR2 are ␣2,3-linked.
We previously reported that MAG binds NgR2 with greater affinity than NgR1 (Venkatesh et al., 2005) . Initially, to identify epitopes within NgR2 that may contribute to enhanced MAG binding, we generated chimeric Nogo receptor variants in which specific domains between NgR1 and NgR2 were swapped. For all receptor mutants, cell surface expression was assessed under nonpermeabilizing conditions and normalized with anti-NgR1-and anti-NgR2-specific mAbs (M5 and P14), which bind to an epitope in the stalk region of NgR1 or NgR2, respectively (Hofer et al., 2007) (Fig. 3A) . MAG binding to chimeric receptors was compared with wild-type NgR2, which was arbitrarily set to 100% (Fig. 3B) . Because MAG(1-5)-Fc binds to NgR1 and NgR2 similar to MAG(1-3)-Fc (Fig. 1) , we used both ligand constructs to ask whether receptor mutants can be identified that show preferential binding of MAG(1-5)-Fc over MAG(1-3)-Fc.
Consistent with our previous observations, oligomerized MAG(1-5)-Fc binds substantially stronger to NgR2 (100%) than to NgR1 (24 Ϯ 4%) (Venkatesh et al., 2005) . A chimeric receptor comprised of the NgR1 LRRNT-cap and LRR (1-8.5 ) domains fused to the NgR2 LRRCT-cap and stalk domains (NgR1 LRR8 / NgR2 LRRCT ) binds MAG strongly (120 Ϯ 7%), exceeding the avidity of wild-type NgR2 (Fig. 3) LRRCTϩstalk is constitutively active in primary neurons. A, NgR1 (red) and NgR2 (green) receptor mutants were transiently expressed in COS-7 cells. Cell surface receptor expression was confirmed by immunocytofluorescence (ICF) with the monoclonal antibodies M5 and P14 under nonpermeabilizing conditions. Binding of MAG(1-5)-Fc and MAG(1-3)-Fc, oligomerized with anti-human Fc conjugated to AP, was detected indirectly by AP enzymatic activity. The deletion mutant NgR2
LRRCTϩstalk (construct V) is sufficient to support high-affinity MAG binding, exceeding the binding strength of wild-type NgR2. Remarkably, the NgR2 stalk is sufficient to support MAG binding (construct IX) and most of its binding activity appears to reside with the proximal stalk region (construct X). None of the constructs examined showed preferential binding of MAG(1-5)-Fc over MAG(1-3)-Fc. B, Quantification of MAG(1-5)-Fc binding in relative AP units. Constructs V and VI are N-terminally myc-tagged and anti-myc staining was used to calibrate the relative binding strength of the NgR1-and NgR2-specific IgGs M5 and P14. Binding to wild-type NgR2 was set equal to 100%. Error bars represent SEM from at least three independent experiments. C, Quantification of neurite length of P7 CGNs transfected with receptor deletion constructs. CGNs transfected with eGFP (white bars) are strongly inhibited when cultured on CHO-MAG feeder cells and extend significantly longer neurites ( p Ͻ 0.05) when cultured on control CHO feeder cells. Overexpression of NgR2
LRRCTϩstalk (green, construct V) results in neurite outgrowth inhibition in the absence of MAG. Conversely, overexpression of NgR1 LRRCTϩstalk (red, construct VI) in CGNs leads to a significant attenuation of MAG inhibition. Neurite length was measured from four independent assays; Ͼ100 neurites were measured per condition for each assay. *p Ͻ 0.05, significantly different from neurons grown on control substrate (unpaired t test). Error bars are in SEM. Scale bar, 30 m.
binding to NgR2
LRRCTϩstalk (277 Ϯ 40%) is enhanced (Fig. 3) . The strong association of MAG with NgR2
LRRCTϩstalk (residues 264 -420) is in marked contrast to NgR1
LRRCTϩstalk (residues 263-473), a corresponding construct of NgR1, which fails to support MAG binding. Together, these results confirm and expand our previous observation that the structural basis of the NgR1-and NgR2-MAG association is very different. Furthermore, we identified the deletion mutant NgR2
LRRCTϩstalk as the minimal NgR2 fragment capable of conferring high-affinity MAG binding. (Fig. 3B ). This suggests that the LRRCT-cap and stalk domains of NgR2 harbor distinct and dissociable MAG docking sites, both of which are necessary for high-affinity MAG binding. Because of the comparably weak binding to both chimeric receptors, it is conceivable that the two MAG binding sites of NgR2 function cooperatively to generate a high-affinity MAG-NgR2 recognition complex. Alternatively, because Cys 335 and Cys 336 of NgR1 are not conserved in NgR2, disulfide bonds formed between the LRRCT-cap domain and proximal stalk sequences of NgR1 (Wen et al., 2005) are disrupted in chimera NgR1 LRRCT /NgR2 stalk , which may result in considerable structural alterations that reduce binding of MAG to the stalk of NgR2.
Identification of distinct MAG binding sites in the

MAG binds to a 13 aa motif in the NgR2 stalk
To more directly address the importance of the NgR2 stalk for MAG binding, we generated the deletion mutant NgR2 stalk , lacking amino acid residues 1-314, which includes the entire LRR cluster (domains LRRNT-LRR-LRRCT). As shown in Figure 3 , expression of the NgR2 stalk alone is sufficient to support MAG binding. Compared with wild-type NgR2, however, MAG binding to NgR2 stalk is reduced to 55 Ϯ 7%. Moreover, deletion of 13 aa residues from the N terminus of the NgR2 stalk, including residues P315-S327, results in NgR2 stalk⌬13 , a mutant that supports MAG binding poorly (9 Ϯ 1%). Selective deletion of P315-S327 from full-length NgR2 (NgR2 ⌬P315-S327 ) decreases binding to 41 Ϯ 11% compared with wild-type NgR2 (Fig. 3B) . Of note, none of the receptor mutants examined showed preferential binding of MAG(1-5)-Fc over MAG(1-3)-Fc, confirming our observation that NgR1 and NgR2 complex with MAG independently of Ig4 and Ig5. Together, these results reveal that a 13 aa sequence motif (PTRPGSRARGNSS) within the NgR2 stalk, located proximal to the LRRCT-cap domain, harbors an important MAG-binding epitope. Because the 13 aa motif is not conserved in NgR1, our analysis provides a molecular explanation for the enhanced binding of MAG to NgR2 compared with NgR1.
The receptor deletion mutants NgR1
LRRCT؉stalk and NgR2
LRRCT؉stalk exhibit opposite activities in primary neurons Thus far, our structural studies identified the deletion mutant NgR2
LRRCTϩstalk as the minimal receptor fragment that confers high-affinity MAG binding. MAG binding to NgR2
LRRCTϩstalk is enhanced compared with full-length NgR2. To ask whether NgR2
LRRCTϩstalk is sufficient to augment MAG inhibition if ectopically expressed in primary neurons (CGNs) (Venkatesh et al., 2005) , we expressed NgR2
LRRCTϩstalk in P7 CGNs and assayed neurite outgrowth on CHO or CHO-MAG feeder cells (Fig. 3C) . Interestingly, when cultured on CHO feeder cells, NgR2
LRRCTϩstalk -expressing CGNs show significantly shorter neurites than eGFP-transfected or untransfected neurons. This suggests that NgR2
LRRCTϩstalk functions as a constitutively active receptor that leads to neurite outgrowth inhibition in the absence of MAG. NgR2
LRRCTϩstalk -elicited neurite outgrowth is reversed in the presence of Y27632, suggesting that it occurs through activation of the RhoA-ROCK pathway (supplemental Fig. S5 , available at www.jneurosci.org as supplemental material). When plated on CHO-MAG cells both eGFP and NgR2
LRRCTϩstalk are significantly inhibited compared with eGFP-transfected neurons plated on CHO cells. Because NgR2
LRRCTϩstalk inhibits growth independently of MAG, we wondered whether NgR1
LRRCTϩstalk , the corresponding deletion mutant of NgR1, shows similar activity when expressed in CGNs. As shown in Figure 3C , NgR1
LRRCTϩstalk does not function as a constitutively active growth inhibitory receptor. On CHO feeder cells, neurite length of NgR1
LRRCTϩstalk or eGFP-transfected neurons was indistinguishable. Interestingly, NgR1
LRRCTϩstalk attenuates neurite outgrowth inhibition in CGNs plated on CHO-MAG feeder cells, suggesting that this construct has dominant negative activity. Neurite length of NgR1 LRRCTϩstalk -expressing neurons is significantly increased compared with eGFP-transfected or nontransfected neurons. Together, these observations suggest that the LR-RCT and stalk sequences of NgR1 and NgR2 have opposite activities when expressed in primary neurons. Thus, sequences C-terminal to the array of LRR (1-8.5) exhibit receptor-specific features and are emerging as important regulators of Nogo receptor function.
The stalk region of NgR1 attenuates Nogo-66 and OMgp binding
While the NgR1 LRR cluster (residues 27-310) is sufficient for Nogo-66, OMgp, and MAG binding , we previously reported that the NgR1 stalk region influences Nogo-66 binding strength (Venkatesh et al., 2005) . Here, we confirm and expand on this initial observation by showing that Nogo-66 and OMgp binding to NgR1 increases to 428 Ϯ 50% and 601 Ϯ 40% if the NgR1 stalk is replaced by the corresponding sequences of NgR2. Similarly, deletion of the NgR1 stalk (NgR1 ⌬stalk ) leads to a significant increase in Nogo-66 and OMgp binding while MAG binding is largely unaltered (Venkatesh et al., 2005) . The reason for the enhanced binding of Nogo-66 and OMgp to receptor variants lacking the NgR1 stalk is not known. One possibility is that the NgR1 stalk partially masks access to Nogo-66 and OMgp binding sites located within the NgR1 LRR cluster. To test this idea, deletion mutants lacking portions of the NgR1 stalk were generated (supplemental Table 1 (Fig. 4) (Fig. 4 A, B) . This suggests that cysteine loop Cys 309 -Cys 336 of the NgR1 stalk is sufficient to partially block or "mask" access of Nogo-66 and OMgp to docking sites located on the concave face of the NgR1 LRR cluster.
Generation of NgR OMNI , a receptor variant that exhibits enhanced binding of OMgp, MAG, and Nogo-66
The preceding results suggest that proximal stalk sequences of NgR1 (P314-C335) negatively regulate binding of Nogo-66 and OMgp to the NgR1 LRR cluster and that sequences in the proximal stalk region (1-5), Nogo-66, and OMgp to the chimeric receptor NgR1(NT-LRR-CT)/NgR2(stalk) (construct II) is greatly enhanced. The proximal stalk sequences of NgR1 (residues 314 -335) are part of the cysteine loop formed between Cys309 and Cys335 and were found to be necessary (construct IV) and sufficient (construct III) to attenuate binding of Nogo-66 and OMgp to NgR1. Deletion of residues 314 -348 of the proximal stalk region of NgR1 and simultaneous insertion of the 13 aa MAG-binding motif identified in the NgR2 stalk (residues 315-327) results in NgR OMNI , a construct which combines the high-affinity binding properties of wild-type NgR1 toward Nogo-66 and OMgp with the high-affinity binding properties of wild-type NgR2 toward MAG. B, Quantification of OMgp (white bars), Nogo-66 (black bars), and MAG(1-5)-Fc (gray bars) binding to receptor variants, normalized to wild-type NgR1. Ligand binding is shown in relative AP units. Error bars represent SEMs and are the result of at least four independent experiments. The interactions of NgR1 with OMgp, Nogo-66, and MAG were each arbitrarily set at 100%. C, Sequence alignment of the proximal stalk regions of wild-type NgR1 (red; residues 309 -352), wild-type NgR2 (green; residues 4 310 -331), and wild-type NgR3 (yellow; residues 304 -346). The NgR1 stalk region G314-C335 was found to partially attenuate or "mask" binding of Nogo-66 and OMgp to NgR1 and is underlined in red. The 13 aa residue MAG binding motif in the NgR2 stalk (P315-S327) is underlined in green. The NgR2 and NgR3 stalks show a weak degree of sequence conservation (conserved residues are shown in bold and were used as a means to align the proximal stalk sequences of the three Nogo receptors). Chimera III (NgR1(1-335)/NgR2(327-420) includes the "mask" but lacks the MAG-binding motif and supports inhibitor binding very similar to wild-type NgR1. Construct IV (NgR1⌬314 -335) shows that deletion of residues 314 -335 of the NgR1 stalk greatly enhances Nogo-66 and OMgp binding without affecting MAG(1-5)-Fc binding. The construct NgR(OMNI) lacks the NgR1 "mask region" and also includes the NgR2 MAG binding motif P315-S327, and as a result, confers high-affinity binding of all three myelin inhibitory ligands. The position of restriction enzyme sites (SpeI and XbaI) introduced to engineer these receptor mutants are shown in black. Scale bar, 30 m.
of NgR2 (P315-S327) enhance the strength of the NgR2-MAG association. In an attempt to generate a chimeric receptor that combines the enhanced ligand-binding properties of NgR1 
Soluble Nogo receptors show "reverse binding" to membrane-bound inhibitors
The robust binding of NgR OMNI to OMgp, Nogo-66, and MAG prompted us to explore whether a soluble variant of this receptor possesses MAG or CNS myelin antagonistic properties and how it compares to those previously reported for NgR(310)ecto, also known as NgR1(310)-Fc, in overcoming neurite outgrowth inhibition . NgR1(310)-Fc is comprised of the dimerized NgR1 LRR cluster (residues 27-310) fused to the Fc region of human IgG1. In a first series of experiments, we assessed binding of soluble receptor variants to membrane-bound inhibitors. As shown in Figure 5A , NgR1(310)-Fc associates specifically with membrane-bound Nogo-66, OMgp, and L-MAG expressed in COS-7. Under similar conditions, soluble NgR2-Fc or AP-Fc fail to interact with membrane-bound Nogo-66 and OMgp, indicating that the weak binding observed with NgR1(310)-Fc is specific. Membrane-bound MAG (L-MAG) shows the following binding preference (Fig. 5) . Binding of soluble NgR OMNI -Fc and NgR1(310)-Fc to membrane-bound Nogo-66 (147 Ϯ 1% and 106 Ϯ 9%, respectively) and OMgp (151 Ϯ 8% and 116 Ϯ 3%) at 100 nM is only modestly increased compared with NgR1-Fc (100%) and binding of NgR OMNI -Fc to L-MAG is comparable to NgR2-Fc but nearly 10-fold stronger than for NgR1(310)-Fc (Fig. 5 A, B) . Thus, NgR OMNI -Fc combines and exceeds the inhibitor-binding activities of NgR1-Fc and NgR2-Fc. MAG homophilic and heterophilic interactions are sialic acid dependent Previously, it was found that enzymatic removal of terminal sialic acids from MAG-expressing cells results in significantly enhanced binding of gangliosides or erythrocytes (Collins et al., 1997; Tropak and Roder, 1997; Cao et al., 2007) . Commensurate with these reports, VCN treatment of L-MAG-expressing COS-7 cells, results in substantially enhanced binding of NgR1-Fc (4.1-fold), NgR2-Fc (1.6-fold), NgR2
LRRCTϩstalk -Fc (1.4-fold), and NgR OMNI -Fc (1.4-fold) compared with control L-MAG cells not treated with VCN (Fig. 5 A, B) . Most notably, binding of NgR1(310)-Fc to L-MAG increases nearly 10-fold from 37 Ϯ 10% before VCN treatment to 354 Ϯ 14% following VCN treatment. A control construct, AP-Fc, does not bind to membranebound L-MAG either before or after VCN treatment (Fig. 5 B, C) . The enhanced binding of soluble receptor variants to desialylated MAG cells suggests that terminal sialic acids on MAG itself, or on other cell surface glycans, compete with sialic acid moieties on soluble Nogo receptors for complex formation with the MAG lectin. Similar to the MAG-NgR1 and MAG-NgR2 heterophilic interactions, MAG homophilic binding is regulated in a sialic acid-dependent manner (supplemental Fig. S2 , available at www. jneurosci.org as supplemental material). Together, these results suggest the existence of numerous carbohydrate ligands recognized by the MAG lectin, and similar to other siglecs, MAG function may be regulated by overall levels of cis-and trans-sialic acid associations (Varki and Angata, 2006) . CTϪstalk -Fc, and NgR OMNI -Fc, completely abolishes binding to L-MAGexpressing COS-7 cells (Fig. 5) . Moreover, a soluble form of the NgR2 stalk (NgR2 stalk -Fc) is sufficient to associate with L-MAG in a sialic acid-dependent manner (supplemental Fig. S6 , available at www.jneurosci.org as supplemental material). The NgR2 stalk sequence harbors a consensus sequence for N-glycosylation, N325-S327 (NSS), that falls within the 13 aa region critical for MAG binding (Fig. 4C) . To examine whether N-glycosylation at N325 is important for MAG binding, we generated NgR2 stalk(N325E) -Fc, a mutant defective for N-glycosylation. cortical neurons in a dose-dependent manner (supplemental Fig.  S7 , available at www.jneurosci.org as supplemental material). Inhibition is MAG specific as it is reversed in the presence of a MAG function-blocking antibody (supplemental Fig. S7E , available at www.jneurosci.org as supplemental material).
Substrate-adsorbed MAG-Fc, but not siglec3-Fc, leads to a significant inhibition of neurite outgrowth of both cortical neurons and CGNs. Neurite length of CGNs is decreased to 65% on MAG-Fc compared with no ligand control or siglec-3 (Fig. 6 ) and neurite length of cortical neurons is decreased to 58% on MAG-Fc compared with no ligand control or siglec-3 (Fig.  6 B, D) . Bath application of soluble NgR OMNI -Fc (10 g/ml) but not NgR1 (310) (Fig. 6 B, D) . Together, these results demonstrate that in neurite outgrowth inhibition assays with two different types of primary neurons NgR OMNI -Fc significantly attenuates MAG inhibition. For a more detailed characterization of NgR OMNI -Fc, we performed a dose-response experiment and also compared its efficacy to NgR1(310)-Fc in neutralizing MAG inhibition. Soluble receptors were added to the culture medium at a final concentration of 0 -20 g/ml. In addition, we compared the efficacy of these two fusion proteins to a soluble version of the minimal MAG receptor, NgR2
LRRCTϩstalk -Fc (Fig. 7) . We found that NgR OMNI -Fc and NgR2
LRRCTϩstalk -Fc, at a final concentration of 5 g/ml (or higher), significantly enhance neurite outgrowth of E18 cortical neurons plated on MAG substrate ( p Ͻ 0.001). Moreover, at 5 g/ml or above both fusion proteins lead to significantly enhanced neurite length compared with NgR1(310)-Fc (Fig. 7B) . Within the concentration range tested, NgR1(310)-Fc failed to significantly release MAG inhibition. Consistent with previous reports Zheng et al., 2005 , He et al., 2003 , however, we observed that NgR1(310)-Fc significantly attenuates inhibition of CGNs cultured on substrate-bound Nogo-66 (data not shown).
NgR
OMNI -Fc binds to endogenously expressed myelin inhibitor and blocks CNS myelin inhibition From a therapeutic point of view, a more relevant question concerns the efficacy of NgR OMNI -Fc in attenuating the growth inhibitory action of adult spinal cord myelin. To ask whether soluble receptors complex with endogenously expressed MAG, we performed affinity precipitation experiments with myelin extracts obtained from adult rat spinal cord tissue. Western blot analysis revealed the presence of Nogo-A, MAG, and OMgp in spinal cord myelin extracts (supplemental Fig. S8 , available at www.jneurosci.org as supplemental material). MAG is enriched in the myelin membrane fraction compared with the microsomal fraction; Nogo-A, on the other hand, is enriched in the microsomal fraction compared with the myelin membrane fraction; and OMgp shows equal distribution between the two fractions (supplemental Fig. S8 , available at www.jneurosci.org as supplemental material). As shown in Figure 8 A Similar to neurite outgrowth experiments on substrate-bound MAG-Fc, we assayed NgR OMNI -Fc and NgR1(310)-Fc for overcoming neurite outgrowth inhibition of CNS myelin. When plated on myelin substrate, neurite outgrowth is decreased to 61% for CGNs and 66% for cortical neurons. Myelin does not completely abolish neurite outgrowth, as in our assays we use low concentrations of laminin or fibronectin, growth-promoting ECM molecules which can partially override myelin inhibition (David et al., 1995; Laforest et al., 2005) . Soluble NgR OMNI -Fc significantly attenuates myelin inhibition ( p Ͻ 0.05), while NgR1(310)-Fc and control human IgG do not release inhibition (Fig. 8) . There is a dose-dependent trend for NgR1(310)-Fc to overcome myelin inhibition of CGNs ( p value 0.22) and cortical neurons ( p value 0.26) in this experimental paradigm, but the increase in neurite length is not statistically significant. As shown in Figure 8 A, NgR1(310)-Fc does not complex with spinal cord myelin derived MAG in an affinity precipitation experiment. Because the spinal cord myelin isolated for our studies is rich in MAG (supplemental Fig. S8 , available at www.jneurosci.org as supplemental material), this may explain why NgR1(310)-Fc does not lead to a significant release of growth inhibition. Other myelin inhibitors such as Nogo-A and OMgp, however, are also present in detergent extracts of spinal cord myelin used for growth inhibition experiments (supplemental Fig. S8 B 
The growth inhibitory site of MAG does not directly bind to NgR1 or NgR2
The first three Ig-like domains of the MAG ectodomain are sufficient to support binding of NgR1 and NgR2. In marked contrast, domains Ig3-5 of MAG fail to associate with NgR1 or NgR2. Functional studies with substrate-adsorbed MAG ectodomain deletion constructs revealed that the bulk of MAG inhibitory activity is associated with MAG(3-5)-Fc, a finding consistent with a previous report showing that a MAG inhibitory site is located in domain Ig5 (Cao et al., 2007) . A trend toward decreased neurite length was found when neurons were cultured on substrate adsorbed MAG(1-3)-Fc, however, neurite length was not significantly shorter when compared with control cultures. Consistent with this observation, neurite length of P5 CGNs cultured on CHO control cells or CHO cells stably expressing membrane-bound MAG(1-3) is virtually identical (Cao et al., 2007) . Thus, we conclude that the Nogo receptor binding site in the MAG ectodomain is distinct from the site that signals growth inhibition.
Implications for Nogo receptor function
The molecular dissection of the MAG ectodomain into a NgR1 and NgR2 binding fragment (Ig1-3) and a growth inhibitory A, C, Neurite outgrowth of P7-P8 rat cerebellar granule neurons (CGNs) (A) and E18 rat cortical neurons (C) is inhibited by substratebound MAG (Siglec-4), but not by Siglec-3. In the presence of NgR OMNI -Fc (10 g/ml) or the function-blocking antibody mAb513 (25 g/ml), MAG inhibition is greatly attenuated. In contrast, NgR1(310)-Fc (10 g/ml) does not lead to a significant release of MAG inhibition. For quantification of neurite length, cultures were fixed and immunolabeled with TuJ1. B, D, Neurite length of P7-P8 CGNs (B) and neurite length of E18 cortical neurons (D) on control substrate and on substrate-bound MAG-Fc in the presence or absence of NgR OMNI -Fc and NgR1(310)-Fc. In the absence of MAG, neither NgR OMNI -Fc nor NgR1(310)-Fc influences neurite outgrowth. For CGNs, 45-278 neurites were measured per condition for each of three independent assays. *p Ͻ 0.001 compared with control; **p Ͻ 0.005 compared with MAG-Fc only; n.s., not statistically significant. For cortical neurons, 15-262 neurites were measured per condition for each of three independent assays. Results are presented as the mean Ϯ SEM. *p Ͻ 0.05 compared with control; **p Ͻ 0.05 compared with MAG-Fc only (unpaired t test). Scale bar, 10 m. a 13 aa motif of the NgR2 stalk region. Thus, the NgR2-MAG complex seems to form an exception to the general rule of LRR protein ligand interactions, as the LRRNT-cap and LRR(1-8.5) domains are dispensable for high-affinity ligand binding. The bulk of MAG binding is mediated by a short sequence motif located in the NgR2 stalk, outside of the NgR2 LRRNT-LRR-LRRCT cluster. Future studies will be needed to determine whether NgR2 forms a complex with one MAG molecule (1:1) through the engagement of two different sites, similar to glycoprotein Ib␣ (GpIb␣) and vWF (Huizinga et al., 2002) , or whether NgR2 is capable of supporting binding of two MAG molecules (1:2), similar to the GpIb␣ complex with thrombin (Celikel et al., 2003; Dumas et al., 2003) .
Deletion of a 20 aa region within cysteine loop 309 -335 of NgR1 leads to a significant increase in Nogo-66 and OMgp binding. This suggests that the proximal stalk region of NgR1 partially blocks access of Nogo-66 and OMgp to the NgR1 LRR cluster. Residues 309 -335 of NgR1 may undergo posttranslational modification(s) or participate in NgR1 homophilic or heterophilic cisinteractions, and, as a result, partially mask access of Nogo-66 and OMgp to receptor docking sites.
In addition to regulating ligand binding strength, the C-terminal sequences of NgR1 and NgR2 participate in receptor function. Deletion of the NgR1 stalk results in a receptor variant with dominant negative activity toward Nogo-66, MAG, and OMgp (Domeniconi et al., 2002; Fournier et al., 2002) . Here, we identify the deletion mutant NgR2
LRRCTϩstalk as the minimal NgR2 receptor sufficient to confer high-affinity MAG binding. Functional studies in primary neurons further revealed that NgR2
LRRCTϩstalk behaves as a constitutively active inhibitory receptor whereas NgR1
LRRCTϩstalk has dominant negative activity and partially attenuates MAG inhibition. Thus, sequences C-terminal to LRR (1-8.5) harbor receptor-specific features and are emerging as important regulators of Nogo receptor function.
NgR
OMNI -Fc, a novel tool to overcome CNS myelin inhibition Antibody-based strategies and soluble receptor ectodomains that directly bind and neutralize myelin inhibitors have been used successfully to promote neurite outgrowth in vitro (Caroni and Schwab, 1988; Fournier et al., 2002) and regenerative axonal growth following spinal cord injury in vivo (Bregman et al., 1995; Huang et al., 1999; Li et al., 2004; Wang et al., 2006) . Whether complexing of myelin inhibitors with antibodies or Fc-fusion proteins simply neutralizes their inhibitory activity or also leads to enhanced clearance of myelin debris is not well understood (Vargas and Barres, 2007) . While exact mechanisms await further elucidation, these studies validate the concept that acute antagonism of myelin inhibitors following spinal cord injury promotes anatomical and functional repair in rodents. We developed and characterized NgR OMNI -Fc, a soluble receptor variant that associates strongly with the prototypic myelin inhibitors OMgp, MAG, and Nogo-66. Because of its superior binding and inhibitor neutralizing properties over NgR1(310)-Fc in vitro, NgR OMNI -Fc is emerging as a promising new tool that warrants further development to examine its potential to overcome myelin inhibition following CNS injury in vivo. Finally, new roles for NgRs and their ligands in immune system function (David et al., 2008) , synaptic plasticity , and neurodegeneration (Park and Strittmatter, 2007 ) may significantly expand the therapeutic opportunities of NgR OMNI -Fc.
